Skip to main content
. 2020 Nov 2;106(7):674–679. doi: 10.1136/archdischild-2020-319040

Figure 1.

Figure 1

Characteristics of HSCT over time for individuals enrolled in the MPS I Registry. The type of transplant performed showing the source of stem cells is shown in (A). Use of ERT either before or immediately after transplant is shown in (B). ERT, enzyme replacement therapy; HSCT, haematopoietic stem cell transplants; MPS I, mucopolysaccharidosis type I.